Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Non-Current Assets (2020 - 2025)

Arcutis Biotherapeutics has reported Non-Current Assets over the past 6 years, most recently at $21.7 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $21.7 million for Q4 2025, up 66.36% from a year ago — trailing twelve months through Dec 2025 was $83.6 million (up 76.52% YoY), and the annual figure for FY2025 was $21.7 million, up 66.36%.
  • Non-Current Assets for Q4 2025 was $21.7 million at Arcutis Biotherapeutics, roughly flat from $21.8 million in the prior quarter.
  • Over the last five years, Non-Current Assets for ARQT hit a ceiling of $21.8 million in Q3 2025 and a floor of $5.0 million in Q2 2022.
  • Median Non-Current Assets over the past 5 years was $11.6 million (2023), compared with a mean of $11.6 million.
  • Biggest five-year swings in Non-Current Assets: soared 958.56% in 2021 and later fell 13.98% in 2024.
  • Arcutis Biotherapeutics' Non-Current Assets stood at $5.4 million in 2021, then surged by 120.64% to $11.9 million in 2022, then decreased by 7.87% to $10.9 million in 2023, then increased by 19.53% to $13.1 million in 2024, then soared by 66.36% to $21.7 million in 2025.
  • The last three reported values for Non-Current Assets were $21.7 million (Q4 2025), $21.8 million (Q3 2025), and $19.7 million (Q2 2025) per Business Quant data.